Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) over five years because of the United States' demand for confidential data.
This move was revealed after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesman has since stated that the United States was seeking health data for research and commercial purposes while was unwilling to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further talks to secure a deal agreeable to all parties so the country's vital HIV programme can continue.
Broader Context
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance transparency and accountability.
According to reports, Sixteen African countries have so far agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting systems previously set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns over the US deal "are not meant as opposition to America," he added.
"We encourage further discussions with our US partners on how subsequent co-operation could be structured in a way that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that negotiations should continue given that much of the country's HIV programmes were funded by foreign aid.
"If technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.
The situation highlights the complex debate between accepting crucial international aid and protecting a country's data in an increasingly interconnected world.